Palatin Technologies, Inc
Nasdaq PTN · Cranbury, NJ
Works in Cardiovascular · GI & liver · Metabolic & endocrine · Psychiatry · Renal & urogenital · Women's health
Palatin Technologies, Inc is a clinical trial sponsor based in Cranbury, NJ, listed as Nasdaq PTN. It has 2 active clinical trials with 124 planned participants, across 6 therapeutic areas. Since 2021 it has completed 4 trials and stopped 1 early.
Trial track record · since 2021
Financials · Nasdaq PTN
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Palatin Technologies, Inc
Palatin Technologies, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 124 planned participants, in Cardiovascular, GI & liver, Metabolic & endocrine, Psychiatry and other areas. Since 2021 it has completed 4 trials and stopped 1 early.
Palatin Technologies, Inc is based in Cranbury, NJ and is listed as Nasdaq PTN. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Palatin Technologies, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-12-15.
Approve Suite is not affiliated with Palatin Technologies, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.